Standard CPAP therapy for obstructive sleep apnea does not cause heart problems. The confusion stems largely from a single high-profile trial of a different device, adaptive servo-ventilation, which did increase cardiovascular deaths in a specific group of heart failure patients. That finding sent shockwaves through sleep medicine and left many patients wondering whether positive airway pressure of any kind could hurt their heart. The reality is more nuanced and, for most CPAP users, reassuring.
Why the Question Exists in the First Place
Two major clinical trials shaped the modern conversation about CPAP and heart health, and their results are easy to conflate if you only catch the headlines. The first, known as the SAVE trial, enrolled over 2,700 adults with moderate-to-severe obstructive sleep apnea and established cardiovascular disease. After roughly four years, the rate of major cardiovascular events was essentially the same in the CPAP group and the usual-care group, with about 17% of CPAP users and about 15% of controls experiencing an event.1PubMed. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea That was disappointing to researchers who hoped CPAP would clearly prevent strokes and heart attacks, but it did not show CPAP causing harm. The hazard ratio was 1.10, which is statistically indistinguishable from no effect in either direction.
The second trial, SERVE-HF, is the one that genuinely alarmed people. It tested adaptive servo-ventilation, or ASV, in patients who had heart failure with reduced ejection fraction and predominant central sleep apnea. ASV is a more sophisticated machine that adjusts breath-by-breath pressure to counteract a specific breathing pattern. In that population, ASV increased all-cause mortality by about 28% and cardiovascular mortality by 34%, and the trial was stopped early.2PubMed Central. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure A follow-up on-treatment analysis confirmed the finding held up even when accounting for how much patients actually used the device.3PubMed Central. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis
Here is the crucial distinction: ASV and standard CPAP are not the same device, and central sleep apnea and obstructive sleep apnea are not the same condition. Central sleep apnea happens because the brain intermittently fails to signal the muscles to breathe. Obstructive sleep apnea happens because tissue in the throat collapses and physically blocks airflow. CPAP splints the airway open with steady pressure and is the standard treatment for the obstructive type. The SERVE-HF results apply to a narrow clinical scenario where ASV is used in patients whose hearts are already failing and whose breathing disorder originates in the brain, not the throat. If you are using CPAP for garden-variety obstructive sleep apnea, the SERVE-HF result does not apply to you.
How CPAP Actually Affects Your Heart
CPAP delivers a constant stream of pressurized air through a mask. That air pressure does not just keep your airway open; it also changes conditions inside your chest. The increased intrathoracic pressure affects how much blood returns to the heart and how the heart pumps against the resistance of your blood vessels.4PubMed Central. Cardiorespiratory interaction with continuous positive airway pressure In a healthy heart, these changes are minor and well tolerated. In a heart that is already struggling, they can be either helpful or unhelpful depending on the specific problem, which is why doctors pay attention to the type of sleep apnea and the state of the heart before prescribing positive airway pressure.
For most CPAP users, the cardiovascular effects are net positive. Untreated obstructive sleep apnea hammers the cardiovascular system night after night. Each time the airway collapses, oxygen drops, the nervous system fires a stress response, and blood pressure spikes. Over months and years, that pattern promotes high blood pressure, inflammation, arterial stiffness, and irregular heart rhythms. CPAP interrupts all of that by keeping the airway open, maintaining oxygen levels, and preventing those surges.
Blood Pressure Benefits
One of the best-documented cardiovascular effects of CPAP is modest blood pressure reduction, and it shows up most in people whose hypertension is difficult to control. A randomized trial of patients with obstructive sleep apnea and resistant hypertension found that twelve weeks of CPAP lowered 24-hour mean blood pressure by about 3 mmHg more than the control group. The proportion of patients whose blood pressure dipped normally during sleep, a pattern linked to lower cardiovascular risk, roughly doubled in the CPAP group.5JAMA. Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The HIPARCO Randomized Clinical Trial
A few millimeters of mercury may sound trivial, but in the context of resistant hypertension, it is meaningful. Patients who already take multiple blood pressure medications and still can’t reach their target are the ones with the most to gain. Separate research on blood pressure monitoring found that compliant CPAP users who had a non-dipping nighttime blood pressure pattern saw their nighttime readings drop by about 7 mmHg.6European Respiratory Journal. Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring That kind of drop in nighttime blood pressure is harder to achieve with pills alone, because many antihypertensive drugs wear off by the middle of the night.
There is no evidence that CPAP interacts with blood pressure medications in a way that creates problems. A meta-analysis of individual patient data from four randomized trials found no treatment interaction between CPAP and antihypertensive drug use.7PubMed Central. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials So if you are on blood pressure medication and starting CPAP, there is no special pharmacological concern.
CPAP and Heart Rhythm Disorders
Untreated obstructive sleep apnea is closely linked to atrial fibrillation and other heart rhythm disturbances, and CPAP appears to help here as well. One study tracked patients with sleep apnea for three months after starting CPAP and found significant reductions in several types of arrhythmia, including supraventricular and ventricular extra beats, atrial fibrillation, nonsustained ventricular tachycardia, and sinus pauses.8PubMed Central. The impact of continuous positive airway pressure on cardiac arrhythmias in patients with sleep apnea Of the patients who had atrial fibrillation at the start, roughly half were free of it by the three-month checkup.
An even more striking finding comes from patients who have undergone catheter ablation for atrial fibrillation. Among those with severe sleep apnea, long-term CPAP adherence was associated with a dramatically lower rate of very late atrial fibrillation recurrence, the kind that shows up more than a year after ablation. Patients who stuck with CPAP long-term had a recurrence rate of about 8%, compared with roughly 22% in those who did not.9PubMed Central. Impact of Long-Term CPAP Adherence on Recurrence After Atrial Fibrillation Ablation in Patients With Severe Sleep Apnea Even after adjusting for other variables, long-term CPAP use cut the risk of late recurrence by about 70%. For anyone who has been through the discomfort and expense of an ablation procedure, that is a compelling reason to keep the CPAP mask on.
The Adherence Problem
A recurring theme across all of this research is that CPAP only helps if you actually use it, and “actually use it” has a fairly specific threshold. The standard benchmark in sleep medicine is at least four hours per night. Many of the trials showing no cardiovascular benefit, including SAVE, had average CPAP use well below that mark. When researchers in a recent systematic review and meta-analysis separated adherent users from the overall pool, the picture shifted. Among patients who used CPAP for four or more hours per night, the risk of major adverse cardiovascular events dropped by about 29%, and cardiovascular mortality dropped by roughly 64%.10PubMed Central. Role of Continuous Positive Airway Pressure in the Prevention of Cardiovascular Events in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis of Randomized Clinical Trials Non-adherent patients saw no significant benefit.
This is the kind of finding that makes the headline “CPAP doesn’t prevent heart attacks” misleading. A more accurate headline would be “CPAP that people barely use doesn’t prevent heart attacks.” The device works as well as the person uses it, and most trials are intent-to-treat analyses, meaning they count everyone who was assigned to CPAP whether they wore it or stuffed it in a closet.
CPAP and Heart Failure
Heart failure is where the relationship between positive airway pressure and the heart gets most complicated. Many heart failure patients have some form of sleep-disordered breathing, but the type matters enormously. When heart failure patients have obstructive sleep apnea, CPAP can produce real improvements. One trial found that CPAP in heart failure patients with obstructive sleep apnea improved left ventricular ejection fraction from about 25% to about 34%, lowered daytime blood pressure, and reduced resting heart rate.11PubMed. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea An ejection fraction jump of nearly nine percentage points is clinically meaningful and represents a heart that is pumping more effectively.
For heart failure patients with Cheyne-Stokes respiration, a specific type of central sleep apnea where breathing waxes and wanes in a distinctive pattern, CPAP also showed promise. In compliant patients with this breathing pattern, CPAP was associated with an 81% relative risk reduction in the combined outcome of death or need for a heart transplant.12PubMed. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration Patients without that breathing pattern did not see the same benefit. A state-of-the-art review confirmed that while CPAP consistently seems to improve ejection fraction in heart failure, robust data showing it improves hard outcomes like survival across the board are still lacking.13The American Journal of Cardiology. A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure
The danger zone, to be clear, is ASV in heart failure patients with reduced ejection fraction and predominant central sleep apnea. That specific combination produced the harmful results in SERVE-HF, and guidelines now recommend against ASV in that population. Standard CPAP does not carry the same warning.
Treatment-Emergent Central Sleep Apnea
There is one situation where starting CPAP can create a new breathing problem that has potential cardiovascular implications. Some patients who begin CPAP for obstructive sleep apnea develop central apneas that were not present before, a condition called treatment-emergent central sleep apnea. This is not common, but it is well documented. Risk factors include older age, male sex, existing heart disease (especially coronary artery disease, hypertension, or atrial fibrillation), use of opioid medications, and certain technical factors during the initial pressure-setting study, such as pressures that are raised too quickly or set too high.14PubMed Central. Treatment-emergent central sleep apnea: a unique sleep-disordered breathing
In many cases, treatment-emergent central apneas resolve on their own within a few weeks as the brain adjusts to the new breathing conditions. When they persist, doctors may adjust pressures, switch to a different mode of positive airway pressure, or investigate whether an underlying cardiac or neurological issue is driving the central events. The condition is worth knowing about because persistent central apneas can fragment sleep and potentially stress the heart, but it is a treatable complication rather than a reason to abandon therapy.
What Happens When You Skip Nights
If you have been using CPAP and wonder whether skipping it for a few nights is harmless, the answer is that your blood pressure starts creeping up almost immediately. A randomized controlled trial had patients go without CPAP for just five nights and measured the effect. Compared with those who kept using CPAP, the withdrawal group saw their 24-hour systolic blood pressure rise by about 3 mmHg and diastolic by about 2 mmHg.15PubMed Central. Cardiovascular effects after five nights without continuous positive airway pressure for obstructive sleep apnea: a randomized controlled trial Women were hit harder, with systolic pressure rising by about 5 mmHg. Arterial stiffness did not change in that short window, but blood pressure is the earlier domino, and its quick return suggests the cardiovascular stress of untreated sleep apnea reasserts itself fast.
Vascular Stiffness and Inflammation
Beyond blood pressure and rhythm, researchers have looked at whether CPAP improves the health of blood vessel walls. A meta-analysis of 15 randomized controlled trials found that CPAP improved the augmentation index, a measure of arterial stiffness, suggesting that the blood vessels become more flexible with treatment.16Frontiers in Cardiovascular Medicine. Endothelial Function and Arterial Stiffness Should Be Measured to Comprehensively Assess Obstructive Sleep Apnea in Clinical Practice That is a good sign, because stiff arteries are a step on the road to heart disease and stroke.
The picture on inflammation is less clear. One study tracking high-sensitivity C-reactive protein, a commonly used marker of systemic inflammation, found no significant change after three or six months of CPAP therapy. The dominant factor predicting CRP levels was body mass index, not CPAP use.17European Respiratory Journal. Effect of Continuous Positive Airway Pressure (CPAP) on High-Sensitivity C-Reactive Protein levels (hs-CRP) in Patients with Obstructive Sleep Apnea (OSA) This does not mean CPAP has no anti-inflammatory effect, but it suggests that weight management may matter more for that particular marker. Newer research is exploring whether the severity of oxygen drops during sleep, rather than just the number of apneas per hour, might better predict who gets cardiovascular benefit from CPAP. One analysis found that the degree of oxygen-level disruption predicted CPAP’s effect on stress hormones and morning heart rate better than the standard apnea-hypopnea index did.18Sleep Medicine. Relationship between hypoxic burden and cardiovascular effects in OSA – a post hoc analysis of an RCT
Side Effects That Mimic Cardiac Symptoms
Some CPAP users experience side effects that feel like they could be heart-related but are not. The most common is a sensation of chest pressure or fullness, which can be alarming if you are already worried about your heart. This is almost always caused by the air pressure itself or by aerophagia, the swallowing of air into the stomach. A questionnaire study of CPAP users found that flatulence and dry mouth were the most bothersome symptoms, both increasing significantly with CPAP use.19PubMed Central. Gastrointestinal symptoms and CPAP-related aerophagia: A questionnaire study Heartburn, interestingly, went down slightly with CPAP. Gas and bloating from swallowed air can create enough abdominal pressure to feel uncomfortable in the chest, and some patients mistake this for a cardiac symptom. If you experience new chest discomfort after starting CPAP, it deserves medical evaluation, but the odds are good that it is a pressure or air-swallowing issue rather than a heart problem.
Heart Rate Variability and the Autonomic Nervous System
Heart rate variability, the beat-to-beat fluctuation in how fast your heart beats, is often used as a window into autonomic nervous system health. Higher variability generally reflects a balanced nervous system; lower variability can signal stress or cardiovascular risk. One study of 37 patients found that in the short term, CPAP did not significantly change most heart rate variability measures. In patients with severe obstructive sleep apnea, there was actually a shift toward reduced variability after starting CPAP.20PubMed Central. The effect of CPAP therapy on heart rate variability in patients with obstructive sleep apnea That sounds concerning at first glance, but the study was small and the observation period was short. The researchers noted that the response to CPAP may depend on how severe the apnea is, and longer-term studies are needed before drawing conclusions about whether this short-term shift has any clinical meaning.
This is a good example of why isolated physiological measurements can be misleading without clinical context. A temporary dip in heart rate variability during the adjustment period does not mean CPAP is damaging the heart. The body is recalibrating after potentially years of nightly oxygen deprivation and sympathetic nervous system overdrive. Whether the autonomic nervous system ultimately reaches a healthier set point with sustained CPAP use is a question that requires longer follow-up than most existing studies provide.
Who Needs Extra Caution
For the vast majority of people prescribed CPAP for obstructive sleep apnea, the therapy is cardiovascularly safe and likely beneficial. The populations that need careful management are narrower than the anxiety around this topic would suggest:
- Heart failure with central sleep apnea: ASV is contraindicated when ejection fraction is reduced. Standard CPAP is generally acceptable but should be monitored closely, especially if central events appear or worsen during treatment.
- Pre-existing arrhythmias: CPAP tends to improve rhythm disturbances, but treatment-emergent central apneas could theoretically complicate the picture. A follow-up sleep study after starting therapy can catch this.
- Very high pressure settings: Unusually high CPAP pressures can exaggerate the intrathoracic pressure effects and may be less well tolerated in patients with certain cardiac conditions. This is managed through careful pressure titration.
If you have heart disease and are starting CPAP, your sleep specialist and cardiologist should be communicating with each other about which type of sleep apnea you have and what your cardiac function looks like. The device itself is not the risk factor. The risk comes from applying the wrong type of positive airway pressure to the wrong type of sleep apnea in a heart that is already compromised.